Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)

China · Delayed Price · Currency is CNY

7.09

0.00 (0.00%)

Sep 30, 2026, 3:04 PM CST

Market Cap	2.98B -16.8%
Revenue (ttm)	784.40M -2.5%
Net Income	39.18M -59.0%
EPS	0.09 -59.0%
Shares Out	419.95M
PE Ratio	76.04
Forward PE	40.51
Dividend	0.04 (0.56%)
Ex-Dividend Date	Jun 3, 2026

Volume	4,578,350
Open	6.98
Previous Close	7.09
Day's Range	6.98 - 7.18
52-Week Range	6.11 - 8.93
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:300636

Jiangxi Synergy Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals in China and internationally. The company offers API products for anti-epilepsy and pain treatment, anti-inflammatory, gastrointestinal, anti-hypertension, anti-gout, anti-diabetes, anti-thrombotic, urology, non-alcoholic steatohepatitis, idiopathic parkinsonism, hypolipidemic agents, migraine therapy, prostate cancer, en... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2004

Employees 1,623

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300636

Full Company Profile

Financial Performance

In 2025, SHE:300636's revenue was 828.66 million, an increase of 9.19% compared to the previous year's 758.89 million. Earnings were 73.09 million, a decrease of -31.42%.

Financial Statements